Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 83,145 | 64,872 | 60,661 | 61,586 |
| Gross Profit | 83,145 | 64,872 | 60,661 | 61,586 |
| Operating Expenses | 89,434 | 24,937 | 28,248 | 37,449 |
| Operating Income | -6,289 | 39,935 | 32,413 | 24,137 |
| Interest Expense | 9,346 | 10,705 | 7,898 | 7,798 |
| Other Income | 229 | 807 | 57 | 27 |
| Pre-tax Income | -15,406 | 30,037 | 24,572 | 16,366 |
| Income Tax | 11,547 | 10,990 | 8,975 | 6,377 |
| Net Income Continuous | -26,953 | 19,047 | 15,597 | 9,989 |
| Net Income | $-26,953 | $19,047 | $15,597 | $9,989 |
| EPS Basic Total Ops | -1.55 | 0.92 | 0.49 | 0.44 |
| EPS Basic Continuous Ops | -1.55 | 1.29 | 1.47 | 0.47 |
| EPS Diluted Total Ops | -1.55 | 0.85 | 0.36 | 0.44 |
| EPS Diluted Continuous Ops | -1.55 | 1.14 | 0.96 | 0.47 |
| EBITDA(a) | $61,967 | $50,709 | $45,334 | $39,444 |